Literature DB >> 10352924

Polycystic ovary syndrome. Phenotype to genotype.

R S Legro1.   

Abstract

Available studies suggest there is a strong familial component to PCOS regardless of the diagnostic criteria used to ascertain probands and to assign affected status in kindreds. Investigation of all kindred members using the same systematic screen for metabolic and reproductive abnormalities strengthens the validity of conclusions. There is no substitute for direct biometric or biochemical proof of the phenotype. Initial studies by the author and his colleagues suggest that hyperandrogenemia in sisters is a valid phenotype characteristic. Further study is necessary to establish other phenotypes in the families. Large family clusterings of PCOS offer the best opportunity for identifying unique strains of PCOS. These families may represent a homogeneous etiology of the syndrome despite significant phenotypic heterogeneity within a given pedigree. Linkage analysis should be performed between polymorphic markers spaced at regular genetic intervals, and these familial traits may identify critical regions for further investigation.

Entities:  

Mesh:

Year:  1999        PMID: 10352924     DOI: 10.1016/s0889-8529(05)70075-x

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

1.  Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance.

Authors:  E Diamanti-Kandarakis; K Alexandraki; A Bergiele; H Kandarakis; G Mastorakos; A Aessopos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Lawrence Demers; Steve C Wang; Rhonda Bentley-Lewis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

3.  H6PD Gene Polymorphisms (R453Q and D151A) and Polycystic Ovary Syndrome: A Case-Control Study in A Population of Iranian Kurdish Women.

Authors:  Rozita Naseri; Yosra Alimoradi; Maryam Sohrabi; Mostafa Cheraghian Fard; Elahe Barzingarosi; Amir Abdolmaleki; Cyrus Jalili
Journal:  Int J Fertil Steril       Date:  2022-08-21

4.  Association of polycystic ovaries with the use of valproic Acid in jordanian epileptic patients.

Authors:  S Otoom; M Nusier; M Hasan; H Hadidi; R Samawi; A M Younes; M Darweesh; N R Boulatova
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

5.  Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: A study from Pakistan.

Authors:  Rumina Tabassum; Fouzia Imtiaz; Shaheen Sharafat; Shazia Shukar-Ud-Din; Uzma Nusrat
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

6.  Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll.

Authors:  Shirin Kalyan; Millan S Patel; Elaine Kingwell; Hélène C F Côté; Danmei Liu; Jerilynn C Prior
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

7.  An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.

Authors:  Yu Liao; Rong Huang; Yun Sun; Jiang Yue; Jun Zheng; Lihua Wang; Tao Tao; Jing Ma; Shengxian Li; Wei Liu
Journal:  Reprod Biol Endocrinol       Date:  2017-01-26       Impact factor: 5.211

8.  Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.

Authors:  Rong Ju; Wei Wu; Qiuqin Tang; Di Wu; Yankai Xia; Jie Wu; Xinru Wang
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.